Advanced Enzyme Technologies (NSE:ADVENZYMES) LT-Debt-to-Total-Asset: 0.01 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ADVENZYMES Advanced Enzyme Technologies Ltd NSE:ADVENZYMES
89 GF Score
Price ₹324.35
GF Value ₹420.89
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Advanced Enzyme Technologies LT-Debt-to-Total-Asset?

Advanced Enzyme Technologies NSE:ADVENZYMES -1.65% 89 LT-Debt-to-Total-Asset is 0.01 as of Mar. 2026. GuruFocus rates NSE:ADVENZYMES with a GF Score™ of 89/100 and a GF Value™ of ₹420.89 (Modestly Undervalued). The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Advanced Enzyme Technologies's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.01.

Advanced Enzyme Technologies's long-term debt to total assets ratio declined from Mar. 2025 (0.01) to Mar. 2026 (0.01). It may suggest that Advanced Enzyme Technologies is progressively becoming less dependent on debt to grow their business.

Advanced Enzyme Technologies  (NSE:ADVENZYMES) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Advanced Enzyme Technologies LT-Debt-to-Total-Asset Related Terms

Advanced Enzyme Technologies LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Advanced Enzyme Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Enzyme Technologies LT-Debt-to-Total-Asset Chart

Advanced Enzyme Technologies Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.02 0.01 0.01

Advanced Enzyme Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.00 0.01 0.00 0.01
NSE:ADVENZYMES
89GF Score
Advanced Enzyme Technologies Ltd NSE:ADVENZYMES
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Enzyme Technologies LT-Debt-to-Total-Asset Calculation

Advanced Enzyme Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )/Total Assets (A: Mar. 2026 )
=116.56/18387.61
=0.01

Advanced Enzyme Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=116.56/18387.61
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.01 mean?
Advanced Enzyme Technologies (NSE:ADVENZYMES) has a LT-Debt-to-Total-Asset of 0.01 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Advanced Enzyme Technologies and its competitors.
Is Advanced Enzyme Technologies' LT-Debt-to-Total-Asset too high?
Advanced Enzyme Technologies' current LT-Debt-to-Total-Asset is 0.01. Overall, Advanced Enzyme Technologies has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Enzyme Technologies' LT-Debt-to-Total-Asset compare to LIN and SHW?
Advanced Enzyme Technologies' LT-Debt-to-Total-Asset of 0.01 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Chemicals company?
A good LT-Debt-to-Total-Asset depends on the Chemicals industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Advanced Enzyme Technologies and its competitors. Advanced Enzyme Technologies's current LT-Debt-to-Total-Asset is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Enzyme Technologies stock overvalued right now?
Based on GuruFocus' analysis, Advanced Enzyme Technologies (NSE:ADVENZYMES) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹420.89, compared to a current price of ₹324.35 — trading 22.9% below its estimated fair value. The current LT-Debt-to-Total-Asset is 0.01. Advanced Enzyme Technologies' overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Advanced Enzyme Technologies (NSE:ADVENZYMES), the current LT-Debt-to-Total-Asset is 0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advanced Enzyme Technologies (NSE:ADVENZYMES) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Enzyme Technologies stock appears to be undervalued. The current stock price of ₹324.35 is trading 22.9% below its estimated GF Value™ of ₹420.89. GuruFocus considers Advanced Enzyme Technologies to be Modestly Undervalued.

Key valuation signals for NSE:ADVENZYMES:

  • LT-Debt-to-Total-Asset: 0.01
  • GF Value™: ₹420.89 vs. price of ₹324.35 (22.9% below fair value)
  • GF Score™: 89/100 with 4 warning signs

No single metric tells the full story. See the NSE:ADVENZYMES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Advanced Enzyme Technologies Business Description

Other Exchanges 540025:India
Address Near LIC Service Road, Sun Magnetica, A Wing, 5th Floor, Louiswadi, Thane (West), Thane, MH, IND, 400604
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The company operates only in one business segment, viz., manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.
89GF Score

Get the complete analysis for NSE:ADVENZYMES

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹324.35
Price
₹420.89
GF Value